GM23899
LCL from B-Lymphocyte
Description:
PRADER-WILLI SYNDROME; PWS
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Chromosome Abnormalities |
Biopsy Source
|
Peripheral vein
|
Cell Type
|
B-Lymphocyte
|
Tissue Type
|
Blood
|
Transformant
|
Epstein-Barr Virus
|
Sample Source
|
LCL from B-Lymphocyte
|
Race
|
White
|
Family History
|
N
|
Relation to Proband
|
proband
|
ISCN
|
46,XY.arr 15q11.2(21142170-22588019)x1,15q11.2(23641501-24542221)x1,15q11.2q12(24787665-27719695)x1
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Remarks |
Clinically affected; diagnosed at 5 days of age; symptom onset at birth; required NG tube until age 3 weeks; mild bitemporal narrowing; mild retrognathia; mild hyperopia; anteverted nose; normal genitalia: Tanner stage 1; shallow sacral dimple; single café au lait lesion; mild apnea; feeding difficulties and reflux until 6 months of age; sitting since 8 months and is walking holding on to furniture at 16 months; weight 24.8 lbs and height 33 inches (90th percentile) at 16 months; average appetite with demonstrated satiety and hunger signals; FISH karyotype: ish 15q11-13(SNRPN-), 15q22(PMLx2), 15p11.2(D15Z1x2); treatments include: Genotropin, coenzyme Q10 carnitine fumarate, creatine monohydrate, fish oil, multivitamin, B12 methylcobalamin; occupational therapy, physical and speech therapy. |
Tang Z, Berlin DS, Toji L, Toruner GA, Beiswanger C, Kulkarni S, Martin CL, Emanuel BS, Christman M, Gerry NP, A dynamic database of microarray-characterized cell lines with various cytogenetic and genomic backgrounds G3 (Bethesda, Md)3:1143-9 2013 |
PubMed ID: 23665875 |
Split Ratio |
1:6 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
AMBIENT |
Medium |
Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not Inactivated |
Substrate |
None specified |
Subcultivation Method |
dilution - add fresh medium |
Supplement |
- |
|
|